Effects of growth hormone receptor antagonism and somatostatin analog administration on quality of life in acromegaly is a research paper published in Clinical Endocrinology (2020). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: K23 DK113220
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: K23 DK115903
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: T32 DK007028
National Center for Advancing Translational Sciences
Grant: UL1 TR001102
National Institutes of Health
Grant: K24 HL092902 (Miller)
National Institutes of Health
Grant: 3T32DK007028-48S1
Training Program in Endocrinology
National Institutes of Health
Grant: 1K23DK113220-01
The Growth Hormone and Insulin-like Growth Factor-1 Axis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
National Institutes of Health
Grant: 4UL1TR001102-04
Harvard Clinical and Translational Science Center
National Institutes of Health
Grant: 5K23DK115903-04
Relative Sarcopenia and Cardiometabolic Risk in Young Adults with Obesity
Harvard Catalyst
National Center for Research Resources
Pfizer
Harvard University
Brigham and Women's Hospital
Influential Citations
1
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals